Live Breaking News & Updates on Michael Horowicz|Page 2

Stay updated with breaking news from Michael horowicz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |BioNTech SE Announcements | BioNTech SE: BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

Investegate announcements from BioNTech SE, BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors ....

John Zhu , Fosun Pharma , Ugur Sahin , Michael Horowicz , Roche Group , Business Development , Duality Biologics Suzhou Co , Drug Administration , Dualitybio Form Global Strategic Partnership , Accelerate Development , Duality Biologics , Mainland China , Hong Kong Special Administrative Region , Macau Special Administrative , Human Epidermal Growth Factor Receptor , Fast Track , Chief Executive Officer , Macau Special Administrative Region , Duality Immune Toxin Antibody Conjugates , New Technologies , Private Securities Litigation Reform Act , Annual Report , Antibody Drug Conjugate , Investegate Announcements , Investegate Company Announcements , Biontech Se ,

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets directed against targets expressed in a broad range of human cancersCollaboration will add. | April 3, 2023 ....

Fosun Pharma , Ugur Sahin , John Zhu , Michael Horowicz , Roche Group , Drug Administration , Duality Biologics Suzhou Co , Duality Biologics , Mainland China , Hong Kong Special Administrative Region , Macau Special Administrative , Human Epidermal Growth Factor Receptor , Fast Track , Chief Executive Officer , Macau Special Administrative Region , Duality Immune Toxin Antibody Conjugates , New Technologies , Private Securities Litigation Reform Act , Annual Report , Antibody Drug Conjugate , Biontech Se Stock Exchange , Press Release , Ill Bntx Us09075v1026 ,

BioNTech and DualityBio Form Global Strategic Partnership

BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets (DB-1303 and DB-1311) directed against targets. ....

John Zhu , Fosun Pharma , Ugur Sahin , Michael Horowicz , Business Development , Drug Administration , Duality Biologics Suzhou Co , Roche Group , Duality Biologics , Mainland China , Hong Kong Special Administrative Region , Macau Special Administrative , Human Epidermal Growth Factor Receptor , Fast Track , Chief Executive Officer , Macau Special Administrative Region , Duality Immune Toxin Antibody Conjugates , New Technologies , Private Securities Litigation Reform Act , Annual Report , Antibody Drug Conjugate , Nasdaq Bntx , Biontech Se , Antibody Drug Conjugates , Ntik 246 Rper Wirkstoff Konjugate ,

BioNTech SE (NASDAQ:BNTX) Q4 2022 Earnings Call Transcript

Michael Horowicz: Good morning and afternoon. Thank you for joining us today for BioNTech s fourth quarter and full year 2022 earnings call. ....

United States , United Kingdom , Hong Kong , Fosun Pharma , Tazeen Ahmad , Michael Horowicz , Ryan Richardson , Ugur Sahin , Jens Holstein , European Commission , National Cancer Institute On Unsplash , European Union , Biontech Group , Exchange Commission , Health Photo , Instadeep Ltd , Call Transcript March , Chief Medical Officer , Chief Financial Officer , Chief Strategy , National Cancer Institute , Annual General Meeting , Chief Strategy Officer , Innovation Series , Insider Trading Websites , Jim Cramer Stocks ,

BioNTech Announces New ADS Repurchase Program

MAINZ, Germany, March 28, 2023 BioNTech SE today announced that it has entered into a new share repurchase program , pursuant to which the Company may purchase American Depositary Shares,. | March 28, 2023 ....

United States , Fosun Pharma , Michael Horowicz , Company Adss , Roche Group , Exchange Commission , Securities Exchange , American Depositary Shares , Securities Exchange Act , New Technologies , Private Securities Litigation Reform Act , Biontech Se Stock Exchange , Press Release , Epositary Bntx Us09075v1026 ,